D1000 Varejo, BRDMVFACNOR9

D1000 Varejo reports BRL 668.47 million revenue. D1000 Varejo stock draws seven ratings

Published on 10/01/2026 at 18:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Analysts set a BRL 7.14 target, implying 18.80 percent upside. D1000 Varejo stock receives three Hold and four Sell ratings from seven analysts.

D1000 Varejo, BRDMVFACNOR9, Illustration mit AI erstellt.
D1000 Varejo, BRDMVFACNOR9, Illustration mit AI erstellt.

D1000 Varejo Farma Participacoes (BRDMVFACNOR9) reported BRL 668.47 million in revenue for the quarter reported on August 31, 2026. The figure and the accompanying BRL 3.25 million net income were published by Investing.com. The same source shows seven analyst ratings for D1000 Varejo stock, including three Holds and four Sells.

Revenue edges higher

Revenue increased from BRL 660.39 million in the previous quarter to BRL 668.47 million in the quarter reported on August 31, 2026. That is a BRL 8.08 million sequential increase, while net income rose from BRL 1.52 million to BRL 3.25 million over the same comparison.

The profit change is the sharper part of the release. Net income more than doubled sequentially, yet the absolute result remains modest relative to sales, keeping profitability central to the investment case.

Analysts see limited upside

Eulerpool lists an average 12-month price target of BRL 7.14 and a latest quoted price of BRL 6.01 in its September 2026 overview. The target is 18.80 percent above that quoted price, based on the same BRL currency. Four of seven analysts carry Sell ratings, while three recommend Hold, giving the consensus a cautious tilt.

Eulerpool also reports fiscal 2025 revenue of BRL 2.55 billion, operating profit of BRL 83.89 million and net income of BRL 22.57 million. Revenue rose from BRL 2.16 billion in fiscal 2024, while net income declined from BRL 25.86 million, showing the tension between expansion and bottom-line conversion.

Market value and business profile

D1000 Varejo Farma Participacoes operates a Brazilian pharmacy chain selling medicines, generic drugs, personal-care products and beauty items, according to Investing.com. The company is classified in the non-cyclical consumption sector and Consumer Staples Distribution and Retail industry.

Stock valuation context

D1000 Varejo had a market capitalization of BRL 304.1 million and a 52-week range of BRL 4.51 to BRL 7.50 on September 23, 2026. The quoted BRL 6.01 level was 19.87 percent above the 52-week low, while the average analyst target stood below the 52-week high.

D1000 Varejo at a glance

  • Company: d1000 Varejo Farma Participacoes S.A.
  • ISIN: BRDMVFACNOR9
  • Ticker: DMVF3
  • Primary exchange: B3
  • Market capitalization: BRL 304.1 million (as of September 23, 2026)
  • 52-week range: BRL 4.51-7.50 (as of September 23, 2026)
  • Sector / Industry: Non-cyclical consumption / Consumer Staples Distribution and Retail

More news and analyses on D1000 Varejo stock

Disclaimer...

en | BRDMVFACNOR9 | D1000 VAREJO | boerse | 70211917 | bgmi